{
    "info": {
        "nct_id": "NCT05213936",
        "official_title": "Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color: A Clinical and Mechanistic Study",
        "inclusion_criteria": "1. Age >= 18 years\n2. Female\n3. Hair type 3 (curly) or type 4 (kinky)\n4. Diagnosis of breast cancer or non-small cell lung cancer (NSCLC) or gynecologic cancer stage I-IV\n5. Patient will be starting >= 4 cycles of taxane-based chemotherapy treatment for curative intent after enrollment\n\n   a. Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed\n6. Eastern Cooperative Oncology Group (ECOG) 0-2: fully active, restrictive in physically strenuous activity, ambulatory and capable of self-care\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Hair type other than 3 or 4\n2. Male\n3. Use of hair weave or extensions without plans to remove\n4. Concurrent malignancy including hematologic malignancies (i.e. leukemia or lymphoma)\n5. Alopecia Common Terminology Criteria for Adverse Events > grade 1 at baseline\n6. Past chemotherapy administration if past treatment was <= 10 years ago\n7. History of migraines or cluster headaches, anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid dysfunction, cold urticaria, cold agglutinin disease, scalp metastases\n8. Planned bone marrow ablation chemotherapy or skull irradiation\n9. Pregnant patient",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Diagnosis of breast cancer or non-small cell lung cancer (NSCLC) or gynecologic cancer stage I-IV",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of breast cancer",
                    "criterion": "breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... non-small cell lung cancer (NSCLC)",
                    "criterion": "non-small cell lung cancer (NSCLC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... gynecologic cancer stage I-IV",
                    "criterion": "gynecologic cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "stage"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "stage"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "a. Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed",
            "criterions": [
                {
                    "exact_snippets": "Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed",
                    "criterion": "concurrent HER therapy",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed",
                    "criterion": "concurrent cisplatin therapy",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed",
                    "criterion": "concurrent cyclophosphamide therapy",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent HER, cisplatin, cyclophosphamide therapies and doxorubicin therapies allowed",
                    "criterion": "concurrent doxorubicin therapy",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Female",
            "criterions": [
                {
                    "exact_snippets": "Female",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Age >= 18 years",
            "criterions": [
                {
                    "exact_snippets": "Age >= 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Eastern Cooperative Oncology Group (ECOG) 0-2: fully active, restrictive in physically strenuous activity, ambulatory and capable of self-care",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "fully active, restrictive in physically strenuous activity, ambulatory and capable of self-care",
                    "criterion": "functional status",
                    "requirements": [
                        {
                            "requirement_type": "activity level",
                            "expected_value": [
                                "fully active",
                                "restrictive in physically strenuous activity",
                                "ambulatory and capable of self-care"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patient will be starting >= 4 cycles of taxane-based chemotherapy treatment for curative intent after enrollment",
            "criterions": [
                {
                    "exact_snippets": "Patient will be starting >= 4 cycles of taxane-based chemotherapy treatment",
                    "criterion": "taxane-based chemotherapy treatment",
                    "requirements": [
                        {
                            "requirement_type": "planned_cycles",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "cycles"
                            }
                        },
                        {
                            "requirement_type": "treatment_intent",
                            "expected_value": "curative"
                        }
                    ]
                },
                {
                    "exact_snippets": "after enrollment",
                    "criterion": "chemotherapy treatment timing",
                    "requirements": [
                        {
                            "requirement_type": "start_time",
                            "expected_value": "after enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Hair type 3 (curly) or type 4 (kinky)",
            "criterions": [
                {
                    "exact_snippets": "Hair type 3 (curly) or type 4 (kinky)",
                    "criterion": "hair type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "3",
                                "4"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "9. Pregnant patient",
            "criterions": [
                {
                    "exact_snippets": "Pregnant patient",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Concurrent malignancy including hematologic malignancies (i.e. leukemia or lymphoma)",
            "criterions": [
                {
                    "exact_snippets": "Concurrent malignancy",
                    "criterion": "concurrent malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hematologic malignancies (i.e. leukemia or lymphoma)",
                    "criterion": "hematologic malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Male",
            "criterions": [
                {
                    "exact_snippets": "Male",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Past chemotherapy administration if past treatment was <= 10 years ago",
            "criterions": [
                {
                    "exact_snippets": "Past chemotherapy administration if past treatment was <= 10 years ago",
                    "criterion": "past chemotherapy administration",
                    "requirements": [
                        {
                            "requirement_type": "time since treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Alopecia Common Terminology Criteria for Adverse Events > grade 1 at baseline",
            "criterions": [
                {
                    "exact_snippets": "Alopecia Common Terminology Criteria for Adverse Events > grade 1 at baseline",
                    "criterion": "alopecia (CTCAE grade) at baseline",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "CTCAE grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Planned bone marrow ablation chemotherapy or skull irradiation",
            "criterions": [
                {
                    "exact_snippets": "Planned bone marrow ablation chemotherapy",
                    "criterion": "bone marrow ablation chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Planned ... skull irradiation",
                    "criterion": "skull irradiation",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. History of migraines or cluster headaches, anorexia, severe anemia, uncontrolled diabetes, hepatitis, thyroid dysfunction, cold urticaria, cold agglutinin disease, scalp metastases",
            "criterions": [
                {
                    "exact_snippets": "History of migraines or cluster headaches",
                    "criterion": "migraines",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of migraines or cluster headaches",
                    "criterion": "cluster headaches",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "anorexia",
                    "criterion": "anorexia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "severe anemia",
                    "criterion": "anemia",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled diabetes",
                    "criterion": "diabetes",
                    "requirements": [
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis",
                    "criterion": "hepatitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "thyroid dysfunction",
                    "criterion": "thyroid dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cold urticaria",
                    "criterion": "cold urticaria",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cold agglutinin disease",
                    "criterion": "cold agglutinin disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "scalp metastases",
                    "criterion": "scalp metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Hair type other than 3 or 4",
            "criterions": [
                {
                    "exact_snippets": "Hair type other than 3 or 4",
                    "criterion": "hair type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": {
                                "operator": "!=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": {
                                "operator": "!=",
                                "value": 4,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Use of hair weave or extensions without plans to remove",
            "criterions": [
                {
                    "exact_snippets": "Use of hair weave or extensions without plans to remove",
                    "criterion": "use of hair weave or extensions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "plans to remove",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}